At2g37460 Antibody

What is At2g37460 and why is it significant for plant research?

At2g37460 (AtUmamiT12) is a WAT1-related protein in Arabidopsis thaliana that functions as an amino acid transporter. Its significance stems from its role in nutrient transport in plants, particularly in phloem loading processes. Research indicates that At2g37460 and its orthologs in other species, such as UmamiT21a in maize, are specifically expressed in phloem parenchyma cells and abaxial bundle sheath cells, suggesting a specialized role in nutrient transport between these tissues . Understanding this protein is crucial for research into plant vascular development, nutrient allocation, and adaptation to environmental stresses. The protein's conservation across plant species further highlights its evolutionary importance in plant physiology.

How should At2g37460 antibodies be stored to maintain optimal binding affinity?

At2g37460 antibodies should be stored according to strict protocols to preserve their binding affinity. Based on antibody storage research, monoclonal antibodies (mAbs) are highly sensitive to storage conditions that can compromise their target recognition capabilities. Store antibodies at 4°C for short-term use (1-2 weeks) or at -20°C to -80°C for long-term storage with minimal freeze-thaw cycles (ideally fewer than 5) . Always aliquot antibodies before freezing to avoid repeated freeze-thaw cycles. Research demonstrates that exposure to organic solvents during handling can significantly reduce antibody binding affinity . Additionally, avoid protein denaturation by preventing exposure to extreme pH conditions, high salt concentrations, and mechanical stress. Always centrifuge antibody solutions briefly before use to remove any aggregates that may have formed during storage.

What controls should be included when validating an At2g37460 antibody for immunolocalization experiments?

When validating an At2g37460 antibody for immunolocalization experiments, comprehensive controls are essential to ensure reliable results. Include the following controls:

• Negative controls:

  • Primary antibody omission (to detect non-specific binding of secondary antibody)

  • Secondary antibody omission (to assess autofluorescence)

  • Pre-immune serum (if available)

  • Wild-type tissue vs. At2g37460 knockout tissue (critical for specificity validation)

• Positive controls:

  • Tissues known to express At2g37460 based on transcript analysis (e.g., phloem parenchyma in Arabidopsis)

  • Recombinant At2g37460 protein

  • Tissues with At2g37460-GFP fusion protein expression

• Cross-reactivity assessment:

  • Test on closely related proteins, particularly other UmamiT family members

  • Use of blocking peptides specific to the epitope

• Method validation:

  • Compare antibody staining patterns with in situ hybridization results for At2g37460 mRNA

  • Compare with GUS or fluorescent protein reporter lines (e.g., SWEET13a-GUS transgenic lines used a similar approach in related research)

Always document signal-to-noise ratios and perform replicate experiments to ensure reproducibility of immunolocalization patterns.

How can TR-FRET assays be optimized for measuring At2g37460 antibody binding kinetics?

Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) assays can be precisely optimized for measuring At2g37460 antibody binding kinetics through several critical adjustments. This high-sensitivity technique eliminates background and scattered light through time-resolved detection, making it ideal for protein-protein interaction studies .

For optimal TR-FRET assay conditions with At2g37460 antibodies:

• Fluorophore selection and labeling:

  • Use terbium (Tb)-cryptate as a donor fluorophore attached to recombinant At2g37460 protein via a 6His tag

  • Conjugate Alexafluor-488 (AF488) maleimide to a Fab' fragment from the antibody as the acceptor fluorophore

  • Determine optimal dye-to-protein ratios through titration experiments

• Concentration optimization:

  • Utilize the lowest antigen concentration that provides good signal-to-noise (typically 250 pM-1 nM based on similar antibody studies)

  • Avoid antigen excess above 1 nM as this may reduce apparent KI values

  • Maintain tracer concentration at minimally sufficient levels to saturate the antigen

• Equilibration conditions:

  • Monitor association at multiple time points (2-40 hours) at 4°C to ensure equilibrium is reached

  • Plot apparent KD values against time to determine true equilibrium

• Data analysis approach:

  • Fit normalized dose-response curves by reductive approximation to exact analytical equations for binary complexes

  • Implement the Morrison equation for tight-binding interactions when depletion of free ligand occurs

This approach provides highly accurate binding affinity measurements that can be used for quality control of antibodies and to detect subtle differences in binding properties due to antibody modifications or storage conditions .

What strategies can resolve cross-reactivity between At2g37460 antibodies and other UmamiT family members?

Resolving cross-reactivity between At2g37460 antibodies and other UmamiT family members requires a multi-faceted approach that combines bioinformatic analysis, epitope selection, and comprehensive validation strategies.

Advanced cross-reactivity resolution strategies:

• Epitope analysis and antibody design:

  • Perform phylogenetic analysis of the UmamiT transporter family to identify unique regions in At2g37460

  • Select epitopes from unique regions with minimal sequence homology to other UmamiT transporters

  • Use multiple unique epitopes (as done with SWEET13 probes) to enhance specificity

  • Consider designing antibodies against UTR regions when protein sequences are highly conserved

• Pre-adsorption techniques:

  • Express and purify closely related UmamiT proteins

  • Pre-adsorb antibodies with these related proteins to remove cross-reactive antibodies

  • Validate the specificity of the remaining antibody fraction

• Knockout validation system:

  • Use CRISPR/Cas9 knockout lines of At2g37460

  • Test antibody in both wild-type and knockout tissues to confirm specificity

  • Employ complementation lines expressing tagged At2g37460 as positive controls

• Competition assays:

  • Implement peptide competition assays using unique and shared epitopes

  • Quantify binding reduction to determine cross-reactivity profiles

  • Utilize TR-FRET competition assays with purified UmamiT family members to measure specific binding constants

• Orthogonal validation:

  • Compare antibody localization patterns with in situ hybridization results using unique probe sets

  • Design probe regions with at least 100 bp of unique sequence in 5'-UTR, 3'-UTR, and coding regions

  • Generate and compare against translational reporter lines (e.g., At2g37460-GUS fusions)

This comprehensive approach ensures that antibodies against At2g37460 can be reliably used in systems where multiple UmamiT family members may be expressed, providing confidence in experimental results and interpretations.

How can RNA in situ hybridization complement antibody studies of At2g37460 expression patterns?

RNA in situ hybridization provides powerful complementary data to antibody-based studies of At2g37460 expression patterns, offering independent verification and additional insights into gene regulation. The combination of these techniques enables researchers to distinguish between transcriptional and post-transcriptional regulation events.

Integration of RNA in situ hybridization with antibody studies:

• Probe design for maximum specificity:

  • Select three unique regions (~100 bp each) in the 5'-UTR, 3'-UTR, and coding sequence of At2g37460

  • Perform sequence alignments using tools like Geneious to verify probe uniqueness

  • Generate both sense (control) and antisense probes using SP6 RNA polymerase with DIG-labeled UTP

• Methodological approach:

  • Extract RNA from tissues of interest using phenol-chloroform extraction

  • Synthesize cDNA and clone probe template regions into vectors like pJET1.2

  • Prepare DIG-labeled RNA probes with a 1:2 ratio of DIG-labeled UTP:UTP

  • Perform hybridization at optimal stringency (55°C) followed by stringent washes with 0.2x SSC

  • Detect hybridization using anti-DIG antibodies and colorimetric development with NBT/BCIP

• Comparative analysis with antibody results:

  • Map expression at cellular resolution in identical tissue types

  • Quantify signal intensities for both techniques to identify potential post-transcriptional regulation

  • Document temporal differences between mRNA and protein expression

  • Identify cell types showing discrepancies between transcript and protein levels

• Advantages of the combined approach:

  • Detects cases where protein trafficking occurs between cells (mRNA in one cell type, protein in another)

  • Reveals post-transcriptional regulation mechanisms

  • Identifies potential regulatory functions of non-coding RNAs

  • Allows distinction between primary sites of gene expression and protein function

In studies of related transporters, this combined approach revealed that SWEET13a-c transcripts and proteins show distinct localization patterns between the abaxial bundle sheath cells and phloem parenchyma in maize, demonstrating the complementary nature of these techniques .

What are the critical parameters for comparing At2g37460 expression between C3 and C4 plant species?

When comparing At2g37460 expression between C3 and C4 plant species, researchers must account for fundamental differences in leaf anatomy, cell-type specialization, and evolutionary adaptations that influence transporter expression patterns.

Critical experimental design parameters:

• Homology and orthology analysis:

  • Conduct comprehensive phylogenetic analysis to identify true orthologs of At2g37460 in C4 species

  • Use BLAST searches with At2g37460 as the seed sequence across multiple plant genomes

  • Verify orthology through synteny analysis and protein domain conservation

• Cell-type specific sampling:

  • Account for the different leaf anatomies and bundle sheath specializations between C3 and C4 plants

  • Implement laser capture microdissection or protoplast isolation with cell-type markers

  • Use single-cell RNA sequencing (scRNA-seq) to resolve cell-type specific expression

  • Compare functionally equivalent cells between species rather than morphologically similar ones

• Developmental stage matching:

  • Select comparable developmental stages based on both anatomical and molecular markers

  • Account for different rates of leaf maturation between C3 and C4 species

  • Sample multiple developmental stages to capture temporal expression dynamics

• Antibody validation across species:

  • Test antibody cross-reactivity with the orthologous proteins in each species

  • Determine epitope conservation through sequence alignment

  • Validate antibody specificity in each species independently

  • Prepare species-specific antibodies when epitopes are not conserved

• Quantitative comparison approach:

  • Normalize expression data to appropriate reference genes validated for both C3 and C4 species

  • Use absolute quantification methods (e.g., digital PCR) rather than relative methods when possible

  • Implement spike-in controls to enable cross-species normalization

In comparative studies, researchers identified that SWEET13 transporters, which interact with UmamiT transporters in phloem loading pathways, show different expression patterns between C3 (Arabidopsis) and C4 (maize) plants. In Arabidopsis, these transporters are primarily expressed in phloem parenchyma, while in maize, they are found in both phloem parenchyma and abaxial bundle sheath cells , highlighting the importance of cell-type resolution in comparative studies.

How can multiplexed immunolabeling be optimized to study At2g37460 co-localization with other transporters?

Multiplexed immunolabeling enables simultaneous visualization of At2g37460 and other transporters, revealing intricate spatial relationships and potential functional interactions. Optimizing this approach requires careful consideration of antibody compatibility, detection systems, and image analysis methods.

Optimization strategies for multiplexed immunolabeling:

• Antibody selection and validation:

  • Choose primary antibodies raised in different host species to enable simultaneous detection

  • Validate each antibody independently before multiplexing

  • Test for cross-reactivity between secondary antibodies and non-target primary antibodies

  • Verify that antibody binding is not altered when used in combination

• Fluorophore selection and spectral separation:

  • Choose fluorophores with minimal spectral overlap

  • Implement spectral unmixing for closely overlapping fluorophores

  • Consider quantum dots for narrow emission spectra and resistance to photobleaching

  • Use sequential scanning on confocal microscopes to eliminate bleed-through

• Sample preparation optimization:

  • Test multiple fixation protocols to preserve epitope accessibility for all targets

  • Optimize antigen retrieval methods for each antibody

  • Determine optimal permeabilization conditions that work for all targets

  • Test different blocking agents to minimize background while preserving specific signals

• Controls and quantification approach:

  • Include single-labeled controls for each antibody to establish baseline signals

  • Implement fluorescence minus one (FMO) controls to account for spectral overlap

  • Use colocalization analysis with Pearson's or Mander's coefficients

  • Apply object-based colocalization for more accurate spatial relationship analysis

Recommended transporter combinations for At2g37460 studies:

This multiplexed approach has been successfully applied to related transporter systems, revealing complementary expression patterns between SWEET13a-c and SUT1 sucrose transporters in maize, which informed models of phloem loading mechanisms .

What are the most common causes of false negative results in At2g37460 antibody experiments and how can they be resolved?

False negative results in At2g37460 antibody experiments can arise from multiple sources during sample preparation, antibody handling, or detection processes. Understanding these issues and implementing appropriate solutions is critical for obtaining reliable results.

Common causes and solutions for false negative results:

• Epitope masking during fixation:

  • Problem: Overfixation with paraformaldehyde or glutaraldehyde can cross-link proteins excessively, making epitopes inaccessible

  • Solution: Test multiple fixation protocols with varying fixative concentrations (1-4% PFA) and durations (10-60 minutes); implement antigen retrieval methods such as heat-induced epitope retrieval or enzymatic digestion

• Antibody storage and handling issues:

  • Problem: Inappropriate storage conditions leading to antibody degradation and loss of binding affinity

  • Solution: Store antibodies according to manufacturer recommendations; avoid repeated freeze-thaw cycles; confirm antibody activity with positive controls before experimental use

• Insufficient permeabilization:

  • Problem: Inadequate membrane permeabilization preventing antibody access to intracellular epitopes

  • Solution: Optimize detergent concentration (Triton X-100, Tween-20, or saponin) and treatment duration; for cell wall-containing samples, consider enzymatic digestion with cellulase/pectinase combinations

• Low abundance target protein:

  • Problem: At2g37460 expression levels below detection threshold in certain tissues

  • Solution: Implement signal amplification methods such as tyramide signal amplification (TSA); increase antibody concentration or incubation time; use more sensitive detection systems like quantum dots or photomultiplier tubes

• Developmental or environmental regulation:

  • Problem: At2g37460 expression varying with developmental stage or environmental conditions

  • Solution: Test multiple developmental stages; verify expression patterns with in situ hybridization ; examine plants grown under different environmental conditions that might regulate transporter expression

• Species-specific epitope variations:

  • Problem: Antibodies raised against Arabidopsis At2g37460 failing to recognize orthologs in other species

  • Solution: Perform sequence alignment of orthologs; design antibodies against conserved regions; validate antibodies specifically for each species under study

Verification approaches to confirm true negatives:

By systematically addressing these potential issues, researchers can distinguish between true biological absence of At2g37460 and technical false negatives in their experimental systems.

How can antibody specificity for At2g37460 be definitively validated using appropriate negative controls?

Definitive validation of At2g37460 antibody specificity requires a systematic approach using multiple negative controls to eliminate potential sources of false positive signals and confirm target specificity.

Comprehensive negative control strategy:

• Genetic knockout controls:

  • Generate At2g37460 knockout/knockdown lines using CRISPR/Cas9 or T-DNA insertion

  • Perform side-by-side immunolabeling of wild-type and knockout tissues

  • Analyze residual signal in knockout lines to identify potential cross-reactivity

  • Complement knockout lines with tagged At2g37460 to restore antibody binding

• Pre-adsorption controls:

  • Express and purify recombinant At2g37460 protein

  • Pre-incubate antibody with excess purified antigen

  • Apply pre-adsorbed antibody to wild-type samples

  • Quantify signal reduction compared to non-adsorbed antibody

• Peptide competition controls:

  • Synthesize the specific peptide epitope used for antibody generation

  • Perform concentration-dependent peptide competition assays

  • Plot dose-response curves to determine IC50 values

  • Test competition with related peptides from other UmamiT family members

• Heterologous expression systems:

  • Express At2g37460 in systems naturally lacking the protein (e.g., yeast, mammalian cells)

  • Compare antibody binding between transfected and untransfected cells

  • Include related UmamiT transporters to assess cross-reactivity

  • Implement inducible expression systems to control protein levels

• Antibody isotype controls:

  • Use isotype-matched non-specific antibodies at the same concentration

  • Process in parallel with the specific antibody

  • Quantify background signal for subtraction from experimental samples

  • Match host species and antibody format (polyclonal/monoclonal)

Signal validation analysis:

This multi-faceted approach to negative controls has been successfully implemented for validating antibodies against related transporters like SWEET13, where multiple independent validation methods confirmed the cellular specificity of expression patterns .

How might designer antibodies against At2g37460 be developed for super-resolution microscopy applications?

Developing designer antibodies against At2g37460 for super-resolution microscopy requires innovative approaches that combine advanced molecular engineering with novel labeling technologies to overcome resolution limits in plant cell imaging.

Strategic approaches for super-resolution compatible antibodies:

• Nanobody development:

  • Generate camelid single-domain antibodies (nanobodies) against At2g37460

  • Screen for high-affinity binders using phage display technology

  • Engineer nanobodies with minimal linkage error (<2 nm) to fluorophores

  • Optimize for plant cell wall penetration through size reduction and surface charge modification

• Site-specific fluorophore conjugation:

  • Incorporate unnatural amino acids at defined positions for bio-orthogonal chemistry

  • Utilize sortase-mediated transpeptidation for controlled labeling

  • Implement click chemistry approaches for conjugating small, photostable fluorophores

  • Position fluorophores at optimal orientation relative to the binding site

• Optimized fluorophore properties:

  • Select fluorophores with high photon budgets for STORM/PALM applications

  • Use self-blinking dyes that don't require switching buffers

  • Implement fluorophores with minimal size to reduce linkage error

  • Design paired fluorophores for MINFLUX or DNA-PAINT applications

• Multi-epitope recognition strategy:

  • Develop complementary antibodies targeting different epitopes on At2g37460

  • Engineer binding domains with minimal physical footprint

  • Create bispecific antibodies to enhance binding affinity and specificity

  • Implement proximity-induced quantum yield enhancement between cognate antibody pairs

• Direct genetic integration approaches:

  • Design knock-in strategies to tag endogenous At2g37460 with photoactivatable fluorescent proteins

  • Implement split fluorescent protein complementation for protein interaction studies

  • Use photoactivatable affinity labels for temporally controlled visualization

  • Develop CRISPR-based imaging approaches with fluorophore-conjugated dCas9

Super-resolution compatibility assessment:

These approaches would enable unprecedented visualization of At2g37460 distribution and dynamics in plant cells, potentially revealing nanoscale organization patterns associated with transporter function and regulation that are currently beyond the reach of conventional immunofluorescence methods.

What are the emerging applications of At2g37460 antibodies in understanding evolutionary divergence of transport mechanisms?

At2g37460 antibodies offer powerful tools for investigating evolutionary divergence of transport mechanisms across plant lineages, providing insights into adaptation, specialization, and the molecular basis of physiological innovations.

Emerging evolutionary applications:

• Comparative immunolocalization across plant lineages:

  • Map At2g37460 ortholog localization across phylogenetically diverse species

  • Compare expression patterns between C3, C4, and CAM plants

  • Trace evolutionary recruitment of transporters to specialized cell types

  • Correlate transporter distribution with anatomical innovations

• Antibody-based phyloproteomics:

  • Develop pan-reactive antibodies recognizing conserved epitopes across UmamiT family

  • Implement immunoprecipitation combined with mass spectrometry (IP-MS)

  • Quantify protein abundance across species in specific cell types

  • Correlate protein conservation with functional conservation

• Functional domain conservation analysis:

  • Generate domain-specific antibodies to test epitope conservation

  • Map functional domains that show differential evolutionary pressure

  • Identify species-specific post-translational modifications

  • Correlate antibody reactivity with transport functional assays

• Co-evolution of transporter complexes:

  • Deploy multiplexed immunolabeling to examine co-localization of transporter proteins

  • Track evolutionary shifts in transporter complex composition

  • Analyze spatial relationships between amino acid and sugar transporters

  • Compare protein-protein interactions across species using proximity ligation assays

• Neofunctionalization detection:

  • Use antibodies to identify novel expression domains in different species

  • Correlate expression pattern shifts with sequence divergence

  • Track subcellular localization changes across orthologs

  • Identify cases where duplicated genes show divergent localization patterns

Evolutionary insights from existing research:

Comparative studies between Arabidopsis and maize have already revealed fascinating evolutionary divergence in transporter localization patterns. In Arabidopsis, SWEET transporters are specifically expressed in phloem parenchyma, while in maize, the orthologous SWEET13 transporters are found in both phloem parenchyma and abaxial bundle sheath cells . This evolutionary recruitment of transporters to different cell types represents adaptation to the specialized C4 photosynthetic pathway in maize.

The evolutionary shift in UmamiT transporters likely follows similar patterns, with At2g37460 orthologs potentially showing redistributed expression patterns in C4 plants. Antibodies targeting conserved epitopes in these transporters would enable researchers to track these evolutionary transitions at the protein level across diverse plant lineages, complementing genomic and transcriptomic approaches to understanding plant adaptation and diversification.